JENA MCNALL: Open Payments
NPI 1942929195 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 85 payments from 16 companies in 2025. Trend: 2023 $376 · 2024 $202 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $188 |
| PFIZER INC. | 16 | $154 |
| ABBVIE INC. | 18 | $148 |
| Lilly USA, LLC | 15 | $134 |
| Sumitomo Pharma America, Inc. | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $36 |
| Radius Health, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: NURTEC ODT, Ozempic, GEMTESA, MOUNJARO, QULIPTA, UBRELVY, REXULTI, KISUNLA.
Industry payments across KS — which companies pay providers there.
